Included in the formulation
АТХ:S.01.X Other drugs for the treatment of eye diseases
Pharmacodynamics:Azadentacene activates proteolytic enzymes that function in the anterior chamber of the eye, and protects the sulfhydryl groups of the lens proteins from oxidation. Promotes resorption of opaque proteins of the lens.
Pharmacokinetics:With topical application, systemic absorption is low.
Indications:Cataract (senile, traumatic, congenital, secondary).
Prevention of cataracts
VII.H25-H28.H25 Star cataract
VII.H25-H28.H26 Other cataracts
Contraindications:Individual intolerance.
The cataract started.
Heavy eye diseases
.
Pregnancy and lactation:Possible use in pregnant and lactating women in the case where the expected therapeutic effect exceeds the potential risk of side effects in the fetus or infant.
Dosing and Administration:Two drops in the conjunctival sac 3-5 times a day.
Side effects:Burning, itching in the eyelids, allergic reactions.
Interaction:Clinically significant interactions are not described.
Special instructions:Azazentacene is administered subconjunctival or in the anterior chamber of the eye, the preparation can be used only in the form instillation into the conjunctival cavity.
A long-term course of therapy is prescribed, even with a quick positive effect from use of the drug.
If, after instillation of the drug, a temporary blurred vision, it is recommended refrain from driving a car or working with complex equipment that requires a clear vision.